Kane Biotech Inc. is a Manitoba based company that provides innovative technologies that breakdown and disperse microbial biofilms. Dispersin B is an enzyme that both inhibits and disperses bacterial biofilms. Kane Biotech Inc. has expressed this enzyme protein in E. coli, with the goal of developing Dispersin B based products. Dispersin B yield and cost effective production are critical factors affecting the market opportunities for Kane Biotechâs Dispersin B products, estimated to be $10million in the next few years. Kane Biotech and Dr.
Natural fibres have been used in many industry sectors such as automobiles, aerospace, construction, etc., but their use in the biomedical industry is relatively new. The major obstacle to their use is the lack of information on relevant fibre properties. This project focuses on testing three critical properties: antimicrobial properties, antioxidant properties, and water sorption in flax, hemp, canola, and sweet clover fibres. Testing these properties will be a stepping stone for proving the applicability of natural fibres in biomedical applications.
Join a thriving innovation ecosystem. Subscribe now